The 4 most recent market catalysts affecting $BOLT, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Nov 13, 2026
Corporate Catalyst
Bullish
Impact 95
Bolt Biotherapeutics Reports Q3 2026 Financial Results and Business Update
Bolt Biotherapeutics has undergone a transformative event by acquiring Prana Therapies through a reverse merger and securing $120 million in financing. This not only provides subst…
Oct 24, 2026
Corporate Catalyst
Bullish
Impact 95
Bolt Biotherapeutics Announces Acquisition of Prana Therapies and $120 Million Private Placement
Bolt Biotherapeutics' acquisition of Prana Therapies is a significant strategic move, immediately expanding its therapeutic pipeline with clinical-stage assets. The concurrent $120…
Aug 12, 2026
Corporate Catalyst
Bearish
Impact 75
Bolt Biotherapeutics shares are trading lower after the company reported worse-than-expected Q2 financial results.
The headline indicates a significant negative corporate catalyst for Bolt Biotherapeutics. Worse-than-expected financial results often lead to immediate stock price declines as inv…
Aug 11, 2026
Corporate Catalyst
Bearish
Impact 95
Bolt Biotherapeutics Q2 EPS $(4.57) Misses $(2.88) Estimate, Sales $5.000K Miss $500.000K Estimate
Bolt Biotherapeutics' Q2 earnings report reveals a substantial underperformance, with both EPS and sales falling far short of analyst expectations. The 99.00% sales miss and 99.72%…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.